| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 240 | $80 | $19.3K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 270 | $60 | $14.8K |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 90 | $130 | $10.8K |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 40 | $160 | $5.9K |
| 91322 | This code represents a SARS–CoV–2 vaccine product administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 50 mcg/0.5 mL. | 30 | $140 | $4.9K |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 20 | $160 | $2.6K |
| G0008 | Administration of influenza virus vaccine | 80 | $30 | $2.5K |
| 90688 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It uses split virus technology and is given as a 0.5 mL dose. | 80 | $20 | $1.6K |
| 20610 | In this procedure, the provider inserts a needle through the skin of a patient and into a major joint or bursa and then uses the syringe attachment to the needle to remove fluid or he may inject a… | 30 | $40 | $1.4K |
| 90480 | The provider administers the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19. | 30 | $40 | $1.4K |